Impact of Vitamin D on the Occurrence and Development of Intestinal Diseases: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

What It Covers

This meta-analysis looks at Vitamin D, K2, Magnesium and Zinc.

To determine the impact of vitamin D on the occurrence and progression of intestinal disorders, the authors of this study have conducted a systematic review and meta-analysis.

Why It Was Studied

However, the exact role of vitamin D in the occurrence and development of intestinal diseases is unclear so far.

Who the Included Studies Covered

The relevant studies were searched in PubMed and screened based on inclusion and exclusion criteria.

How the Review Was Done

The quality of full-text studies was assessed using National Heart, Lung, and Blood Institute (NIH) scale.

The study was conducted as per the PRISMA guidelines.

The publication bias was assessed qualitatively using a funnel plot, and heterogeneity among studies was calculated using I2 statistics.

All analyses were done using RevMan 5.0.

What Was Measured

However, the exact role of vitamin D in the occurrence and development of intestinal diseases is unclear so far.

PubMed files the paper under topics including Vitamin D, Randomized Controlled Trials as Topic, Crohn Disease, Colitis, Ulcerative and Inflammatory Bowel Diseases.

The authors tagged it with the keywords heterogeneity, immunity, inflammation, intestinal diseases, meta-analysis and systematic review.

What This Means in Plain Language

This is a meta-analysis of Vitamin D, K2, Magnesium and Zinc.

Its findings take up roughly 4 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2023 (Combinatorial chemistry & high throughput screening), a journal based in United Arab Emirates.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.